title: [Prognostic, diagnostic, and therapeutic prospects of using adiponectine as a biomarker in cardiobascular diseases].
abstract: The role of adipose tissue as an important endocrine organ is today beyond doubt. The adipose tissue is known to be a source of many biologically active substances, adipocitokines, one of them being the adiponectine possessing anti-inflammatory, antiatherogenic and cardioprotective properties; it is believed to be one of prospective biomarkers for risk assessment, for diagnostics and, possibly, for therapy of cardiovascular diseases.
authors: E M
authors: EM
authors: Pal'tseva
authors: A V
authors: AV
authors: Rodina
authors: S V
authors: SV
authors: Konstantinova
authors: N V
authors: NV
authors: Ermakov
authors: D A
authors: DA
authors: Andreev
authors: A L
authors: AL
authors: Syrkin
authors: S E
authors: SE
authors: Severin
mesh_terms: D052242:Adiponectin / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002316:Cardiotonic Agents / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000378:metabolism*; D004702:Endocrine Glands / Q000473:pathology*; D006801:Humans; D011379:Prognosis
chemical_list: C499918:ADIPOQ protein, human; D052242:Adiponectin; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D002316:Cardiotonic Agents